Finance News Network

Company Presentations

Jumbo Interactive (ASX:JIN) Presentation, FNN Investor Event, Aug 17, Sydney

31 Aug 2017 - Jumbo Interactive (ASX:JIN) CEO & Executive Director, Mike Veverka discusses its FY17 results, growth in online lotteries, alliance with a lottery giant & strategy.

Audinate Group (ASX:AD8) Presentation, FNN Investor Event, August 2017, Sydney

31 Aug 2017 - Audinate Group (ASX:AD8) CFO, Rob Goss discusses its FY17 results and the digital transformation of the audio visual (AV) market.

Mitchell Services (ASX:MSV) Presentation, FNN Investor Event Aug 17, Sydney

30 Aug 2017 - Mitchell Services (ASX:MSV) CEO, Andrew Elf discusses its business overview, pick-up in demand for drilling and strategy.

ALE Property Group (ASX:LEP) Presentation, FNN Investor Event, August 2017, Sydney

30 Aug 2017 - ALE Property Group (ASX:LEP) Managing Director, Andrew Wilkinson, discusses FY17 results and outlook.

LifeHealthcare Group (ASX:LHC): Full Year 2017 Results Presentation

29 Aug 2017 - LifeHealthcare Group Limited (ASX:LHC) Managing Director and CEO Matt Muscio discusses FY17 results and outlook.

Rural Funds Group (ASX:RFF), Full Year 2017 Results Presentation

28 Aug 2017 - Rural Funds Group Limited (ASX:RFF) Managing Director David Bryant presents the company's FY17 full year results.

Centuria Capital Group (ASX:CNI): Full Year 2017 Results Presentation

23 Aug 2017 - Centuria Capital Group (ASX:CNI): Group CEO, John McBain presents the company's FY17 full year results.

Auswide Bank (ASX:ABA): Full Year 2017 Results Presentation

22 August 2017: Auswide Bank Ltd (ASX:ABA), Managing Director Martin Barrett, and CFO Bill Schafer, discusses FY17 results and outlook.

Whitehaven Coal (ASX:WHC): Full Year 2017 Results Presentation

21 Aug 2017 - Whitehaven Coal Limited (ASX:WHC) Managing Director and CEO Paul Flynn presents the company's FY17 full year results.

Centuria Metropolitan REIT (ASX:CMA): Full Year 2017 Results Presentation

14 Aug 2017 - Centuria Metropolitan REIT (ASX:CMA): REIT Manager, Nicholas Blake presents the company's FY17 full year results.

Centuria Industrial REIT (ASX:CIP): Full Year 2017 Results Presentation

14 Aug 2017 - Centuria Industrial REIT (ASX:CIP): REIT Manager, Ross Lees presents the company's FY17 full year results.

BrainChip Holdings (ASX:BRN) June Quarter Update Presentation

08 Aug 2017 - BrainChip Holdings Limited (ASX:BRN) CEO, Louis DiNardo provides an update on adoption of its technology, applications and revenues.

Credit Corp Group (ASX:CCP): FY17 Full Year Results Presentation

01 Aug 2017 - Credit Corp Group (ASX:CCP) CEO Thomas Beregi presents the company's FY17 full year results.

Volt Resources (ASX:VRC): Presentation, CEO Sessions, Sydney

30 Jun 2017 - Volt Resources (ASX:VRC), CEO Trevor Matthews presents at the ASX CEO Sessions in Sydney.

Factor Therapeutics (ASX:FTT): Presentation, CEO Sessions, Sydney

28 Jun 2017 - Factor Therapeutics (ASX:FTT): Executive Director, Dr Christian Behrenbruch, presents at the ASX CEO Sessions in Sydney.

Metro Mining (ASX:MMI): Presentation, CEO Sessions, Sydney

28 Jun 2017 - Metro Mining (ASX:MMI): MD and CEO, Simon Finnis, presents at the ASX CEO Sessions in Sydney.

Genex Power (ASX:GNX): Presentation, CEO Sessions, Sydney

26 Jun 2017 - Genex Power (ASX:GNX): Executive Director, Simon Kidston presents at the ASX CEO Sessions in Sydney.

Zenitas Healthcare (ASX:ZNT) Presentation, CEO Sessions, Sydney

23 Jun 2017 - Zenitas Healthcare Limited (ASX:ZNT) CEO and MD Justin Walter presents at the ASX CEO Sessions in Sydney.

AusCann Group (ASX:AC8) Presentation at the ASX Spotlight Series in Hong Kong, 2017

14 Jun 2017 - AusCann Group (ASX:AC8) Managing Director Elaine Darby presents at the ASX Spotlight Series in Hong Kong.

Murray Cod Australia (ASX:MCA) Presentation: ASX Spotlight Series, Hong Kong

09 Jun 2017 - Murray Cod Australia (ASX:MCA) Executive Director Ross Anderson presents at the ASX Spotlight Series in Hong Kong.

Noxopharm (ASX:NOX) Mid-Year Briefing

30 May 2017 - Noxopharm (ASX:NOX) CEO Dr. Graham Kelly and Ian Minns Director Clinical Development and Medical Affairs provide an update on NOX-66 clinical trials, including applic…